Pricing Log in Create free account
Friday 6 November 2026 Export DHR’s income statement to Excel — free account

Danaher Corporation

DHR Healthcare Diagnostics & Research

Danaher Corporation’s revenue for fiscal 2025 (year ended December 2025) was $24.6 billion, up 2.90% from fiscal 2024.

Revenue
+8.28%
EPS
+36.7%
Free cash flow
+19.1%
Total debt
+44.9%

Quarter to September 2026, against a year earlier

229.65 3.31 +1.46%
Market cap
$159.2B
P/E
37.5×
Fwd P/E
36.9×
Dividend yield
0.66%
F-score
6/9
Altman Z
4.52
Beneish M
−2.57
Dividend safety
69/100
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Danaher Corporation (DHR) EV/EBITDA

Alert me on EV/EBITDA

As of 6 November 2026, Danaher Corporation (DHR) trades at a EV/EBITDA of 22.6×. Over the past ten years it has ranged from 9.3× (September 2015) to 30.6× (September 2020); the current reading is higher than 64% of that period. That is below the Diagnostics & Research industry median of 25.0× and above the Healthcare sector median of 8.5×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 24.8× (0.95%)
FY2024 25.0× 0.47%
FY2023 24.9× 33.10%
FY2022 18.7× (29.97%)
FY2021 26.7× 12.43%
FY2020 23.8× 7.61%
FY2019 22.1× 28.67%
FY2018 17.2× (4.73%)
FY2017 18.0× 22.60%
FY2016 14.7× (18.41%)

Quarterly newest first

Period EV/EBITDA Change
Sep 2026 21.9× 8.70%
Jun 2026 20.1× (0.15%)
Mar 2026 20.2× (18.66%)
Dec 2025 24.8× 11.61%
43 more quarters

Against its own ten years

Low 9.3× High 30.6×
Ten-year median 21.0×
Current reading's percentile 64

EV/EBITDA against peers

Company EV/EBITDA
NTRA Natera, Inc. compare n/m
IQV IQVIA Holdings Inc. compare 16.9×
DHR Danaher Corporation 22.6×
TMO Thermo Fisher Scientific Inc. compare 25.0×
A Agilent Technologies, Inc. compare 26.7×
ILMN Illumina, Inc. compare 26.8×
MTD Mettler-Toledo International, Inc. compare 27.8×
IDXX IDEXX Laboratories, Inc. compare 32.1×
WAT Waters Corporation compare 52.1×
Diagnostics & Research industry median 25.0×
Healthcare sector median 8.5×
Market median 10.9×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on DHR